Tackling COVID-19 Using Small-Molecule Drugs

Autor:	Subhendu Karmakar
Rok vydání:	2022
Předmět:	Drug medicine.medical_specialty 2019-20 coronavirus outbreak Coronavirus disease 2019 (COVID-19) business.industry viruses Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) media_common.quotation_subject humanities Pandemic medicine Intensive care medicine business media_common
DOI:	10.1016/b978-0-323-85844-1.00013-1
Popis:	Human civilization is now facing the biggest pandemic of coronavirus disease 2019 (COVID-19) of this century caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Absence of any suitable vaccines makes this virus much more detrimental;various drugs (antiviral drugs and drugs used for other diseases also) are repurposed to cope up with urgent requirements during this emergency period. This chapter will discuss about some of the important small-molecule drug activities and the mechanism of actions used to tackle COVID-19.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::abbaa48015a032c4ea1b194f4b3f6ae0 https://doi.org/10.1016/b978-0-323-85844-1.00013-1 Zobrazit plný text záznamu